Concepedia

Lewis R. Silverman

LR

Statistics

Publications

49

Citations

9.2K

H-Index

31

Active since

1993

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

The University of Texas MD Anderson Cancer Center

University of Maryland, Baltimore

Onconova Therapeutics (United States)

Roswell Park Comprehensive Cancer Center

Lewis R. Silverman is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, hematology, and pharmacotherapy.

Top concepts

Publications per year

1993–2024

49

Publications

49

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg et al. · The Lancet Oncology · 2009 · 2.6K citations · Full text

, , +6

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

Lewis R. Silverman, Erin P. Demakos, Bercedis L. Peterson et al. · Journal of Clinical Oncology · 2002 · 1.8K citations

Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg et al. · Journal of Clinical Oncology · 2009 · 951 citations · Full text

Further Analysis of Trials With Azacitidine in Patients With Myelodysplastic Syndrome: Studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B

Lewis R. Silverman, David R. McKenzie, Bercedis L. Peterson et al. · Journal of Clinical Oncology · 2006 · 549 citations

Impact of Azacytidine on the Quality of Life of Patients With Myelodysplastic Syndrome Treated in a Randomized Phase III Trial: A Cancer and Leukemia Group B Study

Alice B. Kornblith, James E. Herndon, Lewis R. Silverman et al. · Journal of Clinical Oncology · 2002 · 415 citations

1–5 of 49